BIOMARCK PHARMACEUTICALS LTD has a total of 65 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, Singapore and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are KIRIN AMGEN INC, ANCHOR THERAPEUTICS INC and NORTHSTAR BIOLOG PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Singapore | 7 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | China | 5 | |
#5 | Republic of Korea | 5 | |
#6 | Australia | 4 | |
#7 | Brazil | 4 | |
#8 | Israel | 4 | |
#9 | Mexico | 4 | |
#10 | WIPO (World Intellectual Property Organization) | 4 | |
#11 | Hong Kong | 3 | |
#12 | Canada | 2 | |
#13 | New Zealand | 2 | |
#14 | South Africa | 2 | |
#15 | Hungary | 1 | |
#16 | Japan | 1 | |
#17 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Parikh Indu | 53 |
#2 | Adler Kenneth B | 20 |
#3 | Martin Linda D | 8 |
#4 | Indu Parikh | 7 |
#5 | Li Yuehua | 7 |
#6 | Takashi Shuji | 7 |
#7 | Kenneth B Adler | 3 |
#8 | Shuji Takashi | 2 |
#9 | Yuehua Li | 2 |
#10 | Linda D Martin | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020257162A1 | Peptides and methods of use thereof in treating uveitis | |
MX2015014036A | Inhibitors of metastasis. | |
BRPI0714953A2 | Methods to attenuate the release of inflammatory mediators and useful peptides in this regard | |
US2006217307A1 | Methods for regulating inflammatory mediators and peptides useful therein | |
EP1858538A2 | Mucin hypersecretion inhibitors based on the structure of mans and methods of use |